Annals of Oncology Advance Access originally published online on April 20, 2006
Annals of Oncology 2006 17(9):1465; doi:10.1093/annonc/mdl052
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 European Society for Medical Oncology
letters to the editor |
Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy
1 Department of Medical Oncology, Hacettepe University Institute of Oncology Ankara, Turkey
2 Department of Internal Medicine, Beirut Governmental University Hospital, Beirut, Lebanon
3 Department of Clinical Oncology, Hospital Maternidade De Campinas, Campinas, SP, Brazil
*(E-mail: drkadri@usa.net)
| The first 10% of the full text of this article appears below. |
We read the study by Scherwath et al. [1] in which they evaluated the impact of
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A Scherwath Reply to 'Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy' by K. Altundag et al. (Ann Oncol 2006; 17: 1465) Ann. Onc., September 1, 2006; 17(9): 1465 - 1466. [Full Text] [PDF] |
||||
